Tamiflu, the ethyl ester form of oseltamivir carboxylic acid (OC), is the first orally available anti-influenza drug for the front-line therapeutic option. In this study, the OC-hydroxamates, OC-sulfonamides and their guanidino congeners (GOC) were synthesized. Among them, an OC-hydroxamate 7d bearing an O-(2-indolyl)propyl substituent showed potent NA inhibition (IC50 = 6.4 nM) and good anti-influenza activity (EC50 = 60.1 nM) against the wild-type H1N1 virus. Two GOC-hydroxamates (9b and 9d) and one GOC-sulfonamide (12a) were active to the tamiflu-resistant H275Y virus (EC50 = 2.3-6.9 μM).
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bmc.2014.10.005 | DOI Listing |
Publication Analysis
Top Keywords
oseltamivir hydroxamate
4
hydroxamate acyl
4
acyl sulfonamide
4
sulfonamide derivatives
4
derivatives influenza
4
influenza neuraminidase
4
neuraminidase inhibitors
4
inhibitors tamiflu
4
tamiflu ethyl
4
ethyl ester
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!